Rationale and design of Ticagrelor with Aspirin Dual Antiplatelet Therapy Combined with Intravenous Thrombolysis in Patients with Ischemic Stroke (TAPIS): a multicentre, randomised, double-blind, parallel group, placebo-controlled trial
- DOI
- 10.1136/svn-2025-004721
- Published
- 2026-01-29
- Container
- Stroke and Vascular Neurology
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/svn-2025-004721,
title = {Rationale and design of Ticagrelor with Aspirin Dual Antiplatelet Therapy Combined with Intravenous Thrombolysis in Patients with Ischemic Stroke (TAPIS): a multicentre, randomised, double-blind, parallel group, placebo-controlled trial},
author = {Anxin Wang and Xue Xia and Philip M Bath and Guillaume Turc and Jing Li and Xiaoli Zhang and Yilong Wang},
year = {2026},
journal = {Stroke and Vascular Neurology},
doi = {10.1136/svn-2025-004721},
url = {https://doi.org/10.1136/svn-2025-004721}
}RIS
TY - JOUR TI - Rationale and design of Ticagrelor with Aspirin Dual Antiplatelet Therapy Combined with Intravenous Thrombolysis in Patients with Ischemic Stroke (TAPIS): a multicentre, randomised, double-blind, parallel group, placebo-controlled trial AU - Anxin Wang AU - Xue Xia AU - Philip M Bath AU - Guillaume Turc AU - Jing Li AU - Xiaoli Zhang AU - Yilong Wang PY - 2026 JO - Stroke and Vascular Neurology DO - 10.1136/svn-2025-004721 UR - https://doi.org/10.1136/svn-2025-004721 ER -
APA
Wang, A., Xia, X., Bath, P. M., Turc, G., Li, J., Zhang, X., & Wang, Y. (2026). Rationale and design of Ticagrelor with Aspirin Dual Antiplatelet Therapy Combined with Intravenous Thrombolysis in Patients with Ischemic Stroke (TAPIS): a multicentre, randomised, double-blind, parallel group, placebo-controlled trial. Stroke and Vascular Neurology. https://doi.org/10.1136/svn-2025-004721
Source records
- crossref · retrieved 2026-11-05T20:51:47.670Z